Article

baltimoresun.com on 2024-05-25 16:02

Patient advocates merit a voice in FDA drug reviews | READER COMMENTARY

Whatever is broken with FDA drug approval process, it won't be fixed by shutting out patient advocacy groups.

Jim Taylor

Related news

AAdvocates blast CMS for denying access to FDA-approved Alzheimer’s treatment augustafreepress.com
Orawan
Horses, the victims of racing, merit greater attention | READER COMMENTARY baltimoresun.com
Maryland
Terps football doesn’t merit big, new stadium | READER COMMENTARY baltimoresun.com
Florida , St. Augustine , Big Ten , College Park , Maryland
FDA reviews ALS drug after push Arkansas Online
New England , Cambridge , China , Washington , Capitol Hill
DFDA Reviews Operation Amidst Covid-19 dailyguidenetwork.com
The Head
Perhaps only women should be writing abortion laws | READER COMMENTARY baltimoresun.com
Tama-shi , Texas , California , Los Angeles
Where is the support for Alzheimer’s patients? | READER COMMENTARY baltimoresun.com
Washington , New York
FDA skeptical of experimental ALS treatment pushed by patient advocates Seattle Times
White House
???? | READER COMMENTARY baltimoresun.com
Democrat holds up nomination for FDA chief over opioid reviews staradvertiser.com
Massachusetts , Montpelier
FDA plans to expand remote evaluations, record reviews post-pandemic jdsupra.com
Politicians should be chosen on merit, not race or gender | READER COMMENTARY baltimoresun.com
Baltimore
Deadly foot-dragging at the FDA and other commentary New York Post
Beijing , Vatican City , Hong Kong , China , Europe
COMMENTARY: FDA labeling requirements for testosterone replacement overstate risks heralddemocrat.com
Sherman , Lower Austria
FDA still rejects far too many drugs | GUEST COMMENTARY baltimoresun.com
Americas , Japan
Advocates in Minnesota applaud FDA crackdown on flavored tobacco products Star Tribune
Waseca , Eden Prairie , Richfield , North Mankato , Minnetonka
Maine advocates denounce decision revoking FDA approval for abortion pill bangordailynews.com
New England , Texas , Alabama , Tuscaloosa , West Alabama
FDA panel reviews 1st new Alzheimer's drug in 2 decades KING 5